OCUL Insider Holders & Insider Ownership

List of insiders holdings for OCULAR THERAPEUTIX INC:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
SUMMER ROAD LLC 10% Owner	2024-02-27 16:43:51	0 8,591,401	8,591,401	Form 4
Opaleye Management Inc. Previously a 10% owner	2024-02-14 19:48:57	6,070,000 0	6,070,000	Form 13G
Sawhney Amarpreet Chairman of the Board	2019-06-10 16:55:59	1,056,031 1,958,942	3,014,973	Form 4
Versant Venture Capital III L.P. Versant Side Fund III L.P. 10% Owner	2020-02-14 11:19:20	2,215,384 0	2,215,384	Form 13G
Dugel Pravin Executive Chairman	2024-02-26 20:07:55	2,137,448 0	2,137,448	Form 4
CHV II L.P. Ascension Health Ventures II LLC 10% Owner	2015-02-10 15:46:33	2,100,138 0	2,100,138	Form 13G
SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. 10% Owner	2018-02-14 11:18:04	1,605,207 0	1,605,207	Form 13G
Polaris Venture Management Co. V L.L.C. Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. 10% Owner	2016-02-16 17:09:32	1,230,009 0	1,230,009	Form 13G
Mattessich Antony C. President and CEO	2024-02-06 18:26:40	1,138,101 6500	1,144,601	Form 4
Goldstein Michael H. President, Ophthalmology & CMO	2022-02-07 19:29:53	503,335 0	503,335	Form 4
Nayak Sanjay Chief Strategy Officer	2024-02-26 20:06:32	424,850 0	424,850	Form 4
Notman Donald Chief Financial Officer	2024-02-06 18:29:51	380,356 0	380,356	Form 4
Ozden Rabia Gurses Chief Medical Officer	2024-02-06 18:32:10	353,054 0	353,054	Form 4
Strassburger Philip C. General Counsel	2024-02-06 18:35:58	336,493 0	336,493	Form 4
White Christopher G Chief Business Officer	2024-02-06 18:38:53	243,689 0	243,689	Form 4
Kitchen Patricia Chief Operating Officer	2021-02-19 16:31:22	220,000 0	220,000	Form 4
Bollag Daniel M Sr. VP Reg. Affairs & Quality	2019-01-04 18:29:10	180,000 0	180,000	Form 4
LINDSTROM RICHARD L MD Director	2023-06-16 19:05:11	156,402 0	156,402	Form 4
Warden Charles M Director	2023-06-16 19:09:32	96,464 0	96,464	Form 4
Graves Adrienne L Director	2023-07-12 17:18:40	96,000 0	96,000	Form 4
Smith W Bradford CFO and Treasurer	2017-02-10 16:29:59	90,000 0	90,000	Form 4
Fortune James Chief Operating Officer	2017-02-10 16:35:28	90,000 0	90,000	Form 4
Williams Leslie J. Director	2023-06-16 19:08:00	61,433 0	61,433	Form 4
Talamo Jonathan H. Chief Medical Officer	2017-02-10 16:39:06	60,000 0	60,000	Form 4
Ankerud Eric See Remarks	2017-02-10 16:38:34	60,000 0	60,000	Form 4
Hurley Charles Andrew Chief Commercial Officer	2017-02-10 16:36:44	60,000 0	60,000	Form 4
Hong Seung Suh Director	2023-06-16 19:03:51	56,933 0	56,933	Form 4
RAINES MERILEE Director	2023-06-16 19:05:52	56,933 0	56,933	Form 4
Hanley Kevin F. Sr. VP Technical Operations	2019-01-04 18:28:39	50,000 0	50,000	Form 4
PEACOCK BRUCE Director	2021-06-22 20:02:26	18,000 0	18,000	Form 4
OSHEA WILLIAM J Director	2018-06-15 17:23:20	18,000 0	18,000	Form 4
Chadha Jaswinder Director	2018-06-15 17:23:18	18,000 0	18,000	Form 4
Heier Jeffrey S. Director	2023-08-18 20:45:39	17,350 0	17,350	Form 4
GARVEY JAMES M Director	2017-06-01 18:31:36	13,500 0	13,500	Form 4
Crane Alan L Director	2014-07-24 19:14:12	11,363 0	11,363	Form 3
MIGAUSKY GEORGE V Interim CFO	2017-04-12 17:31:44	0 0	0	Form 3

Insider Holders & Insider Ownership - OCULAR THERAPEUTIX INC (OCUL)